888.435.2220
info@medicure.com
MPH.V
Toggle navigation
Home
Products
Aggrastat (tirofiban HCI)
In Development
Business Development
Generic Products
Tardoxal
News
News Releases
Get News Alerts by Email
Investors
Overview
Corporate Presentation
Corporate Governance
About Us
About Medicure
Management
Board of Directors
Careers
Corporate Compliance
Contact
News Releases
News
News Releases
News Releases
Get News Alerts by Email
Get News Alerts by Email
Year
All Years
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Mar 28, 2018
Medicure Announces Further Up-Date on PREXXARTAN®
Mar 19, 2018
Medicure Announces an Up-Date on PREXXARTAN® Launch
Mar 7, 2018
Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.
Feb 1, 2018
Medicure Announces Receipt of Deferred Proceeds from Apicore Sale
Dec 19, 2017
Medicure Announces FDA Approval Received for Prexxartan®
Dec 14, 2017
Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
Nov 21, 2017
Medicure Reports Financial Results for Quarter Ended September 30, 2017
Nov 17, 2017
Medicure Announces Repayment of Outstanding Debt
Nov 15, 2017
Medicure Q3 Results and Conference Call Dates
Oct 31, 2017
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
Oct 3, 2017
Medicure Announces Sale of Apicore Business
Aug 7, 2017
Medicure Reports Financial Results for Quarter Ended June 30, 2017
Aug 2, 2017
Medicure Q2 Results and Conference Call Dates
Jul 12, 2017
Medicure Closes Acquisition of Additional Interests in Apicore
Jul 10, 2017
Medicure Exercises Option to Acquire Additional Interests in Apicore
Jul 3, 2017
Medicure Provides Update on Apicore Purchase Option
May 24, 2017
Medicure Reports Financial Results for Quarter Ended March 31, 2017
May 18, 2017
Medicure Q1 Results and Conference Call Dates
Apr 26, 2017
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
Mar 29, 2017
Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017
Mar 23, 2017
Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Jan 9, 2017
Medicure Provides Apicore Secured Loan to Replace Knight Loan
Dec 13, 2016
Medicure announces filing of ANDA in collaboration with Apicore
Dec 1, 2016
Medicure Closes Acquisition of Majority Interest in Apicore
Nov 18, 2016
Medicure to Hold Investor Call on November 21, 2016
Show
5
10
25
50
100
per page
«
1
2
3
4
5
»